LAMGX | Micro Cap Growth Fund Class A | Lord Abbett
Image alt tag

Error!

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Micro Cap Growth Fund

Summary

Summary

What is the Micro Cap Growth Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of micro and small-sized U.S. companies.

Fund Basicsas of 12/31/2020

Total Net Assets
$189.29 M
Inception Date
08/28/2020
Dividend Frequency
Annually
Fund Gross Expense Ratio
1.16%
Fund Net Expense Ratio
1.06%
Number of Holdings
87

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 79.62% 79.62% 35.46% 28.55% 20.20% -
Lipper Category Avg. Small-Cap Growth Funds 38.35% 38.35% 18.76% 17.68% 13.52% -
Russell Microcap® Growth Index 40.13% 40.13% 14.04% 13.08% 11.57% -

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 79.62% 79.62% 35.46% 28.55% 20.20% -
Lipper Category Avg. Small-Cap Growth Funds 38.35% 38.35% 18.76% 17.68% 13.52% -
Russell Microcap® Growth Index 40.13% 40.13% 14.04% 13.08% 11.57% -

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

TEN LARGEST HOLDINGS as of 12/31/2020View Portfolio

Holding Assets
The Rubicon Project, Inc. 3.6%
Cerence Inc 3.2%
Calix Networks, Inc. 2.7%
Agilysys Inc 2.5%
Digital Turbine Inc 2.5%
Eidos Therapeutics Inc 2.4%
Cardlytics Inc 2.0%
Shockwave Medical Inc 1.9%
Pacific Biosciences of California, Inc. 1.8%
Telos Corp 1.8%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner & Portfolio Manager

33 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

21 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

19 Years of Industry Experience

Steven H. Wortman
Steven H. Wortman

Portfolio Manager

24 Years of Industry Experience

Supported By 5 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 79.62% 79.62% 35.46% 28.55% 20.20% -
Lipper Category Avg. Small-Cap Growth Funds 38.35% 38.35% 18.76% 17.68% 13.52% -
Russell Microcap® Growth Index 40.13% 40.13% 14.04% 13.08% 11.57% -

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 79.62% 79.62% 35.46% 28.55% 20.20% -
Lipper Category Avg. Small-Cap Growth Funds 38.35% 38.35% 18.76% 17.68% 13.52% -
Russell Microcap® Growth Index 40.13% 40.13% 14.04% 13.08% 11.57% -

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

NAV Historical Prices

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 09/30/2020

  • We believe the Fund’s long-term positioning in high innovation stocks and industries should be a tailwind for relative performance. The pandemic has steepened the slope of the adoption curve of many of the trends we are invested in.
  • We believe industries powering the technology revolution – from the cloud to artificial intelligence to biotechnology, medical devices, and ecommerce – are best positioned to weather both cyclical bear markets and corrections with unique catalysts, and benefit from the innovative environment that will likely persist for years.
  • Moreover, unlike many other areas of the economy, we believe that these targeted areas of innovation should continue to exhibit fundamental strength and have the potential for greater relative performance through an economic slowdown, as they continue to displace older businesses and outdated technologies.
  • We believe the backdrop for innovation investing remains favorable because of continued low economic growth and low inflation; in addition, the technology revolution is still in its early stages.

Portfolio Details as of 12/31/2020

Total Net Assets
$189.29 M
Number of Holdings
87
Weighted Average Market Cap.
2.6 B
P/B Ratio
6.9x
Portfolio Turnover Ratio as of 10/31/2019
94.1%
P/E Ratio
36.2x

Contributors & Detractors as of  12/31/2020

Contributors

Holding Contribution
The Rubicon Project, Inc. 4.2%
Cerence Inc 2.3%
Eidos Therapeutics Inc 2.0%
Cardlytics Inc 1.4%
Digital Turbine Inc 1.4%

Detractors

Holding Contribution
Overstock.com, Inc. -0.5%
Limelight Networks, Inc. -0.4%
Vital Farms Inc -0.4%
Duluth Holdings, Inc. -0.2%
Adaptimmune Therapeutics plc -0.2%

Attribution Analysis 

Micro Cap Growth Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Upcoming Dividend Payment Dates

This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
11/22/2021 11/23/2021 11/23/2021

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/23/2020 11/24/2020 $2.8043 $2.2741 $5.0784 $18.90

Upcoming Capital Gain Distribution

This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
11/22/2021 11/23/2021

Fees & Expenses

Fees & Expenses

Expense Ratioas of 12/31/2020

Fund Gross Expense Ratio Fund Net Expense Ratio
1.16% 1.06%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell Microcap® Growth Index measures the performance of those Russell Microcap companies with higher price-to-book ratios and higher forecasted growth values.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field